Mineralocorticoid signaling in transition to heart failure with normal ejection fraction.
Heart failure with normal ejection fraction occurs in elderly patients with hypertensive heart disease. We hypothesized that, in such patients, mineralocorticoid receptor activation accelerates the types of ventricular and vascular remodeling and dysfunction believed important in the transition to heart failure. We tested this hypothesis by administering deoxycorticosterone acetate (DOCA) without salt loading or nephrectomy to elderly dogs with experimental hypertension. Elderly dogs were made hypertensive by renal wrapping. After 5 weeks, dogs were randomly assigned to DOCA (1 mg/kg per day IM; old hypertensive [OH]+DOCA; n=11) or not (OH; n=11) for 3 weeks. At week 8, conscious echocardiography and hemodynamic assessment under anesthesia were performed. DOCA resulted in further increases in conscious blood pressure (P<0.05) without increases in cardiac output or diastolic volume. In the conscious state, effective arterial elastance (P<0.05) and systemic vascular resistance (P=0.06) were increased, and systemic arterial compliance (P<0.05) was decreased in OH+DOCA animals. After anesthesia, instrumentation, and autonomic blockade, blood pressure was lower, whereas left ventricular (LV) systolic elastance, LV diastolic stiffness, and ex vivo myofiber diastolic stiffness were increased in OH+DOCA animals. LV collagen was increased in OH+DOCA animals (P<0.05 for all), but LV mass, LV brain natriuretic peptide, and titin isoform profiles were not. Neither aortic stiffness nor aortic structure was altered in OH+DOCA animals. These findings suggest that age and hypertensive heart disease enhance sensitivity to exogenous mineralocorticoid administration and that mineralocorticoid receptor activation could contribute to the transition to heart failure in elderly persons by promoting increases in LV diastolic and systolic stiffness.
Shapiro
Brian P
BP
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA.
Owan
Theophilus E
TE
Mohammed
Selma
S
Kruger
Martina
M
Linke
Wolfgang A
WA
Burnett
John C
JC
Redfield
Margaret M
MM
D000375:Aging; D000818:Animals; D001011:Aorta / Q000473:pathology / Q000503:physiopathology; D001158:Arteries / Q000503:physiopathology; D015415:Biomarkers / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003094:Collagen / Q000378:metabolism; D003900:Desoxycorticosterone / Q000494:pharmacology; D003971:Diastole; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D004285:Dogs; D004452:Echocardiography; D004548:Elasticity; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology*; D006352:Heart Ventricles; D006973:Hypertension / Q000150:complications* / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging; D008901:Mineralocorticoids / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism; D015398:Signal Transduction; D013318:Stroke Volume; D013599:Systole; D014655:Vascular Resistance; D014666:Vasomotor System / Q000187:drug effects / Q000503:physiopathology; D016277:Ventricular Function, Left
D015415:Biomarkers; D008901:Mineralocorticoids; D003900:Desoxycorticosterone; D003094:Collagen